Table of Contents
Chapter 1. Global Smoking Cessation and Nicotine De-Addiction Products Market Executive Summary
1.1. Global Smoking Cessation and Nicotine De-Addiction Products Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Form
1.3.3. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Smoking Cessation and Nicotine De-Addiction Products Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Smoking Cessation and Nicotine De-Addiction Products Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Awareness and Government Initiatives
3.1.2. Shift Towards E-cigarettes
3.1.3. Technological Advancements in Cessation Products
3.2. Market Challenges
3.2.1. High Cost of Therapies
3.2.2. Limited Compatibility with Existing Systems
3.3. Market Opportunities
3.3.1. Rise in Expenditure on Mobile Phone Accessories
3.3.2. Growth in Online Sales Channels
3.3.3. Increasing Investment in R&D by Market Players
Chapter 4. Global Smoking Cessation and Nicotine De-Addiction Products Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Smoking Cessation and Nicotine De-Addiction Products Market Size & Forecasts by Product 2022-2032
5.1. Segment Dashboard
5.2. Global Smoking Cessation and Nicotine De-Addiction Products Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Nicotine Replacement Therapy Products
5.2.2. Drug Therapy
5.2.3. E-cigarettes
Chapter 6. Global Smoking Cessation and Nicotine De-Addiction Products Market Size & Forecasts by Form 2022-2032
6.1. Segment Dashboard
6.2. Global Smoking Cessation and Nicotine De-Addiction Products Market: Form Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Gum
6.2.2. Inhaler
6.2.3. Tablet
6.2.4. Others
Chapter 7. Global Smoking Cessation and Nicotine De-Addiction Products Market Size & Forecasts by Distribution Channel 2022-2032
7.1. Segment Dashboard
7.2. Global Smoking Cessation and Nicotine De-Addiction Products Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospital Pharmacies
7.2.2. Online Providers
7.2.3. Drug Stores and Retail Pharmacies
Chapter 8. Global Smoking Cessation and Nicotine De-Addiction Products Market Size & Forecasts by Region 2022-2032
8.1. North America Smoking Cessation and Nicotine De-Addiction Products Market
8.1.1. U.S. Smoking Cessation and Nicotine De-Addiction Products Market
8.1.1.1. Product breakdown size & forecasts, 2022-2032
8.1.1.2. Form breakdown size & forecasts, 2022-2032
8.1.1.3. Distribution Channel breakdown size & forecasts, 2022-2032
8.1.2. Canada Smoking Cessation and Nicotine De-Addiction Products Market
8.2. Europe Smoking Cessation and Nicotine De-Addiction Products Market
8.2.1. U.K. Smoking Cessation and Nicotine De-Addiction Products Market
8.2.2. Germany Smoking Cessation and Nicotine De-Addiction Products Market
8.2.3. France Smoking Cessation and Nicotine De-Addiction Products Market
8.2.4. Spain Smoking Cessation and Nicotine De-Addiction Products Market
8.2.5. Italy Smoking Cessation and Nicotine De-Addiction Products Market
8.2.6. Rest of Europe Smoking Cessation and Nicotine De-Addiction Products Market
8.3. Asia-Pacific Smoking Cessation and Nicotine De-Addiction Products Market
8.3.1. China Smoking Cessation and Nicotine De-Addiction Products Market
8.3.2. India Smoking Cessation and Nicotine De-Addiction Products Market
8.3.3. Japan Smoking Cessation and Nicotine De-Addiction Products Market
8.3.4. Australia Smoking Cessation and Nicotine De-Addiction Products Market
8.3.5. South Korea Smoking Cessation and Nicotine De-Addiction Products Market
8.3.6. Rest of Asia Pacific Smoking Cessation and Nicotine De-Addiction Products Market
8.4. Latin America Smoking Cessation and Nicotine De-Addiction Products Market
8.4.1. Brazil Smoking Cessation and Nicotine De-Addiction Products Market
8.4.2. Mexico Smoking Cessation and Nicotine De-Addiction Products Market
8.4.3. Rest of Latin America Smoking Cessation and Nicotine De-Addiction Products Market
8.5. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Products Market
8.5.1. Saudi Arabia Smoking Cessation and Nicotine De-Addiction Products Market
8.5.2. South Africa Smoking Cessation and Nicotine De-Addiction Products Market
8.5.3. Rest of Middle East & Africa Smoking Cessation and Nicotine De-Addiction Products Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. 22nd Century Group Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Cipla Ltd.
9.3.3. Dr. Reddy's Laboratories Ltd.
9.3.4. Imperial Brands Plc. (Fontem Ventures)
9.3.5. Johnson and Johnson (McNeil Consumer Health)
9.3.6. Njoy Company
9.3.7. Perrigo Company Plc.
9.3.8. Rusan Pharma
9.3.9. Zydus Cadila
9.3.10. British American Tobacco Inc.
9.3.11. GlaxoSmithKline PLC (Haleon)
9.3.12. Pfizer Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes